Janet Strong
Nurse Practitioner · Boise, IDNPI 1255418539
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 361 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,203 and has fallen 99.2% since, to $19 in 2024. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 361 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$937
- Supernus Pharmaceuticals, Inc.$702
- Otsuka America Pharmaceutical, Inc.$680
- Johnson & Johnson$452
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$439
- Lundbeck LLC$390
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,63499%
- Education$761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $937 |
| Supernus Pharmaceuticals, Inc. | 45 | $702 |
| Otsuka America Pharmaceutical, Inc. | 42 | $680 |
| Johnson & Johnson | 25 | $452 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $439 |
| Lundbeck LLC | 22 | $390 |
| Teva Pharmaceuticals USA, Inc. | 29 | $380 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $303 |
| Alkermes, Inc. | 19 | $291 |
| Vanda Pharmaceuticals Inc. | 11 | $243 |
| Neurocrine Biosciences, Inc. | 7 | $205 |
| Corium, LLC | 10 | $115 |
| Merck | 7 | $114 |
| Ironshore Pharmaceuticals Inc. | 4 | $90 |
| Eisai Inc. | 5 | $82 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| Sunovion Pharmaceuticals Inc. | 5 | $68 |
| Indivior Inc. | 3 | $44 |
| Tris Pharma Inc | 1 | $43 |
| Janssen Scientific Affairs, LLC | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$140
- INGREZZA$131
- REXULTI$111
- QELBREE$103
How this compares
$5,710 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.
Other nurse practitioner in Boise
- Kathleen CliffordBoise$119K
- Loreen NugentBoise$20K
- John PilcherBoise$11K
- Stephanie OrtensiBoise$6K
- Garhett UlmerBoise$6K
- Mallori HookerBoise$5K
- Megan LarsonBoise$5K
- Dana PeacheyBoise$4K
- Kara GarnerBoise$3K
- Thiago AlbertoBoise$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.